Loading...

Loading...

Donanemab Gains EMA Panel Support for Alzheimer’s Treatment
By MBN Staff - Mon, 07/28/2025 - 08:59
Donanemab receives EMA panel’s recommendation for treating early Alzheimer’s, with implications for healthcare systems across the world.

Partnership Content

Cluster Automotriz Nuevo Leon